Skip to main content
رجوع
Watch Compare

PALISADE BIO, INC.

جودة البيانات: 83%
PALI
Nasdaq Manufacturing Chemicals
KWD 1.95
▲ KWD 0.08 (4.01%)
القيمة السوقية: 326.02 M
السعر
KWD 1.95
القيمة السوقية
326.02 M
نطاق اليوم
KWD 1.88 — KWD 2.02
نطاق 52 أسبوعًا
KWD 0.53 — KWD 2.64
حجم التداول
2,697,605
فتح KWD 1.88
متوسط 50 يوم / 200 يوم
KWD 1.79
8.59% above
متوسط 50 يوم / 200 يوم
KWD 1.48
31.78% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -10.85 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-575.48%
أقل من متوسط القطاع (-53.41%)
ROIC-460.73%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio1.96
Interest Coverage-1805.60

التقييم

PE (TTM)
-19.43
أقل من متوسط القطاع (-1.48)
P/B Ratio101.50
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -19.4 -1.5
P/B 101.5 1.6
ROE % -575.5 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -16.78 M
ROE -575.48% ROA -246.06%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -10.85 M
ROIC -460.73% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.96
Interest Coverage -1805.60 Asset Turnover N/A
Working Capital 3.35 M Tangible Book Value 3.21 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -19.43 Forward P/E N/A
P/B Ratio 101.50 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3.33%
Market Cap 326.02 M Enterprise Value 320.80 M
Per Share
EPS (Diluted TTM) -0.30 Revenue / Share N/A
FCF / Share -0.06 OCF / Share -0.06
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 64.64%
SBC-Adj. FCF -11.17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 0.0 250,000.0 — —
Net Income -16.78 M -14.44 M -12.30 M -14.26 M -26.62 M
EPS (Diluted) -0.30 -10.19 -1.80 -16.53 -3.39
Gross Profit — — — — —
Operating Income -18.06 M -14.86 M -13.07 M -15.72 M -41.85 M
EBITDA — — — — —
R&D Expenses 16.00 M — — — —
SG&A Expenses — — — — —
D&A — — — 3,000.0 2,000.0
Interest Expense 10,000.0 12,000.0 15,000.0 13,000.0 2.40 M
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 134.34 M 10.88 M 14.05 M 15.76 M 12.51 M
Total Liabilities 4.96 M 3.39 M 2.74 M 3.28 M 5.15 M
Shareholders' Equity 129.38 M 7.49 M 11.31 M 12.48 M 7.37 M
Total Debt — — — — 87,000.0
Cash & Equivalents 133.39 M 9.82 M 12.43 M 12.38 M 10.50 M
Current Assets 134.22 M 10.49 M 13.33 M 14.73 M 12.37 M
Current Liabilities 4.64 M 3.24 M 2.59 M 3.01 M 2.50 M